Skip to content

Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03202459
Enrollment
60
Registered
2017-06-28
Start date
2017-03-02
Completion date
2018-01-31
Last updated
2017-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications, Postoperative Nausea and Vomiting

Keywords

Anesthesia, Complications, Nausea, Vomiting

Brief summary

Postoperative nausea and vomiting (PONV) is one of the most commonly reported adverse effects of anesthesia. The general incidence of vomiting is approximately 30%, nausea at 50% and the PONV rate can go up to 80% in high-risk patients without prophylaxis. Prevention of these episodes in high-risk patients improves satisfaction and well-being rates. Therefore, it becomes important the adequate control of PONV, aiming at the satisfaction of the patient with the procedure, lower costs for the health system as well as reduction of complications in the postoperative period. This study aims to evaluate the association of gabapentin or pregabalin with dexamethasone in reducing the incidence of PONV in high-risk patients undergoing laparoscopic surgeries in the first 48 hours postoperatively as well as to assess side effects.

Detailed description

The study included 60 patients at high risk for PONV (Apfel-score 0, I, II, III and IV) scheduled for elective laparoscopic surgeries at the Central Surgical Center of Irmandade da Santa Casa de Misericórdia in São Paulo. Inclusion criteria will be ASA I or II of either sex, in the age range of 18 to 70 years. In this study, the recruited patients will be allocated randomly into three groups. The group A will receive oral 600 mg gabapentin 2 h before surgery. The group B will receive oral 150 mg pregabalin 2 h before surgery. The Group C will receive oral placebo 2 h before surgery and ondansetron 8mg intravenous at the end of the surgery. This study is double-blind, in which neither the doctor nor the patient knows what medicine is being given.

Interventions

DRUGGroup A - gabapentin 600 mg

The patient will receive oral 600 mg gabapentin 2 h before surgery

DRUGGroup B - pregabalin

The patient will receive oral pregabalin 150 mg 2 h before surgery

The patient will receive oral placebo 2 h before surgery and ondansetron 8mg intravenous at the end of the surgery

Sponsors

Faculdade de Ciências Médicas da Santa Casa de São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing laparoscopic procedures * Apfel Score 0, I, II, III and IV * ASA I / II

Exclusion criteria

* Patients with surgery converted to open before thirty minutes of surgery * Patients who were exposed previously to gabapentin or pregabalin Patients who have allergy to any medicine used in the study * Patient who have to any cognitive impairment * Illiterate patients * Patients who refuse to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Postoperative Nausea or vomiting M01 hoursThe occurrence of postoperative nausea or vomiting, in the recovery room, during the first hour after surgery
Postoperative Nausea or vomiting M1212 hoursThe occurrence of postoperative nausea or vomiting, reported by the patient or witnessed by a healthcare provider during the first 12 hours after surgery
Postoperative Nausea or vomiting M2424 hoursThe occurrence of postoperative nausea or vomiting, reported by the patient or witnessed by a healthcare provider during the first 24 hours after surgery
Postoperative Nausea or vomiting M4848 hoursThe occurrence of postoperative nausea or vomiting, reported by the patient or witnessed by a healthcare provider during the first 48 hours after surgery

Secondary

MeasureTime frameDescription
Time to request the first medication for nausea and vomitingFirst hour after surgeryReported by the patient or by a healthcare provider
Amount of medicationDuring the first 30 days after surgeryReported by a healthcare provider
Patient demographic dataBefore surgeryWith a questionnaire will be studied the variables: age, sex, weight, height, BMI
Degree of patient satisfactionBefore dischargeThe patient's overall satisfaction will be assessed using point scales (very satisfied, somewhat satisfied, neither satisfied nor dissatisfied, somewhat dissatisfied, very dissatisfied)
Postoperative complicationsDuring the first 30 days after surgeryPostoperative complications after surgery
Surgical DurationFirst hour after surgeryTime of surgery
Duration of postoperative anesthesia stayFirst hours after surgeryTime to postoperative anesthesia care unit discharge alive (hours)
The length of stay in hospitalFrom end of surgery until hospital discharge or 30 days after surgeryTime of stay in hospital

Countries

Brazil

Contacts

Primary ContactLigia Andrade da Silva Telles Mathias, Doctor
rtimao@uol.com.br+ 55 11 99386-0059
Backup ContactThiago Grigio, Master
grigiotr@gmail.com+55 11 99298-1605

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026